$LIFE

Kucharski Brandt Walter sold $284K of LIFE

Kucharski Brandt Walter (Chief Accounting Officer) sold 8,735 shares of Ethos Technologies Inc. (LIFE) at an average of $32.47 ($32.46–$32.86, $0.28M total) across 2 trades on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Kucharski Brandt Walter
Published Aug 21, 2026, 10:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 10:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LIFE
Neutral
medium confidence
Mentioned
$LIFE
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFENeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, offering limited actionable insight.

02

Market read

Primary insider sale with low materiality; unlikely to move the stock significantly.

03

What to watch

Potential upcoming compensation adjustments or tax planning.

Relevance 3/10Novelty 5/10Timing: filed today

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$LIFENeutralMedium confidence
Context

Chief Accounting Officer sold 8,735 shares for $283.7K via a 10b5‑1 plan.

Expected impact

Minor downward pressure, likely negligible on price.

Evidence & confidence

Sale size is modest relative to float; executed under pre‑arranged plan, limiting informational value.

Market effects

No immediate sector impact; insider activity is company‑specific.

None

None

Counterpoint

Sale could be routine liquidity need, not a negative signal.

Key entities

  • Ethos Technologies Inc.

    Issuer of the Form 4 filing.

  • Kucharski Brandt Walter

    Chief Accounting Officer and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year-over-year to $73 million • Board of Direc